Danish pharmaceutical company Novo Nordisk announced on Friday that chief executive Lars Fruergaard Jørgensen will step down, ...

For the fiscal fourth quarter, adjusted earnings were 38 cents a share on revenue of $138.3 million, comfortably above ...